Atai Life Sciences N.V.

1.47
-0.10 (-6.37%)
At close: Mar 28, 2025, 3:59 PM

Insider Trading

Name Date Shares Price Value Trade Type
Apeiron Investment Group Ltd. 10 % Owner
Mar 24, 2025 1,800,000 $1.40 $2.52M
Bought
Kirpekar Sahil Chief Business Officer
Mar 21, 2025 48,563 $1.35 $65.56K
Sale
Craig Kevin James Chief Medical Officer
Mar 21, 2025 11,563 $1.35 $15.61K
Sale
Rao Srinivas See Remarks
Mar 21, 2025 75,418 $1.35 $101.81K
Sale
Johnson Anne Nagengast Chief Financial Officer
Mar 21, 2025 33,545 $1.35 $45.29K
Sale
Short Glenn Frank Chief Scientific Officer
Mar 21, 2025 13,161 $1.35 $17.77K
Sale

Trade Smarter, Not Harder

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access to all data and tools
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Realtime Options & Dark Pool Data
Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
Top Wallstreet Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.